Cheng‐I Wang

2.5k total citations
37 papers, 1.0k citations indexed

About

Cheng‐I Wang is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cheng‐I Wang has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cheng‐I Wang's work include Mosquito-borne diseases and control (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Viral Infections and Vectors (7 papers). Cheng‐I Wang is often cited by papers focused on Mosquito-borne diseases and control (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Viral Infections and Vectors (7 papers). Cheng‐I Wang collaborates with scholars based in Singapore, United States and United Kingdom. Cheng‐I Wang's co-authors include Charles S. Craik, Lucile Warter, Qing Yang, Sébastien Bertin-Maghit, Rai‐Shung Liu, Hsin‐Yi Liao, Rupsha Chaudhuri, Chia‐Wen Li, Lisa F. P. Ng and Jan Frič and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

In The Last Decade

Cheng‐I Wang

36 papers receiving 1.0k citations

Peers

Cheng‐I Wang

PHEOH

RNMI

ONCOL

Jennifer M. Brannan United States

Thomas Mandel Clausen Denmark

Rolf Fendel Germany

Therèse Visser Netherlands

Brigitte Heller United States

Anasuya Chattopadhyay United States

Susan J. Gagnon United States

Christopher J. McCormick United Kingdom

Kushch Aa Russia

Peter Schoofs Australia

Jennifer M. Brannan United States

Cheng‐I Wang

789 ×2.0

429 ×1.1

PHEOH

330 ×1.3

34 ×0.2

RNMI

85 ×0.5

ONCOL

Citations per year, relative to Cheng‐I Wang Cheng‐I Wang (= 1×) peers Jennifer M. Brannan

Countries citing papers authored by Cheng‐I Wang

Since Specialization

Citations

This map shows the geographic impact of Cheng‐I Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐I Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐I Wang more than expected).

Fields of papers citing papers by Cheng‐I Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐I Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐I Wang. The network helps show where Cheng‐I Wang may publish in the future.

Co-authorship network of co-authors of Cheng‐I Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐I Wang. A scholar is included among the top collaborators of Cheng‐I Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐I Wang. Cheng‐I Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gu, Yue, Kathryn J. Wood, Cheng‐I Wang, et al.. (2024). Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function. Frontiers in Immunology. 15. 1438285–1438285.

Tulsian, Nikhil Kumar, Xinlei Qian, Yue Gu, et al.. (2023). Defining neutralization and allostery by antibodies against COVID-19 variants. Nature Communications. 14(1). 6967–6967. 6 indexed citations

Siddiqui, Asim Azhar, et al.. (2023). A versatile genomic transgenesis platform with enhanced λ integrase for human Expi293F cells. Frontiers in Bioengineering and Biotechnology. 11. 1198465–1198465. 1 indexed citations

Sampei, Zenjiro, Christine X. Koo, Ying Xiu Toh, et al.. (2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 12(2). 36–36. 3 indexed citations

Zeng, Qun, Hiu Yi Wong, Karthik Mallilankaraman, et al.. (2022). Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors. Cancer Immunology Immunotherapy. 71(11). 2583–2596. 15 indexed citations

Nozach, Hervé, Steven G. DuBois, Dimitri Kereselidze, et al.. (2021). Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of ⁸⁹Zr-Labeled Anti-PD-L1 Antibody Formats. Journal of Nuclear Medicine. 63(8). 1259–1265. 23 indexed citations

Wang, Bei, Yun Shan Goh, Tessa Prince, et al.. (2021). Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore. npj Vaccines. 6(1). 125–125. 7 indexed citations

Yong, Kylie Su Mei, Zhisheng Her, Sue Yee Tan, et al.. (2020). Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics. Frontiers in Immunology. 11. 553362–553362. 8 indexed citations

Wei, Junnian, Yung-Hua Wang, Chia Yin Lee, et al.. (2020). An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers. Molecular Imaging and Biology. 22(6). 1553–1561. 8 indexed citations

10.

Low, Lionel, et al.. (2019). Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen. Nature Communications. 10(1). 5382–5382. 40 indexed citations

11.

Rajendran, Sakthi, et al.. (2019). Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells. Frontiers in Oncology. 9. 945–945. 17 indexed citations

12.

Xu, Meihui, Sumathy Velumani, Ying Xiu Toh, et al.. (2017). A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus. npj Vaccines. 2(1). 2–2. 45 indexed citations

13.

Kam, Yiu‐Wing, Cheryl Yi‐Pin Lee, Teck‐Hui Teo, et al.. (2017). Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2(8). 58 indexed citations

14.

Goh, Anthony T.C., Sébastien Bertin-Maghit, Siok Ping Yeo, et al.. (2014). A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy. mAbs. 6(3). 764–772. 38 indexed citations

15.

Frič, Jan, Sébastien Bertin-Maghit, Cheng‐I Wang, Alessandra Nardin, & Lucile Warter. (2012). Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection. The Journal of Infectious Diseases. 207(2). 319–322. 63 indexed citations

16.

Lee, Chia Yin, Yiu‐Wing Kam, Jan Frič, et al.. (2011). Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants. PLoS Pathogens. 7(12). e1002390–e1002390. 83 indexed citations

17.

Schneider, Eric L., et al.. (2011). A Reverse Binding Motif That Contributes to Specific Protease Inhibition by Antibodies. Journal of Molecular Biology. 415(4). 699–715. 42 indexed citations

18.

Wang, Cheng‐I, et al.. (1998). Ecotin: a serine protease inhibitor with two distinct and interacting binding sites. Journal of Molecular Biology. 279(4). 945–957. 45 indexed citations

19.

Wang, Cheng‐I, Qing Yang, & Charles S. Craik. (1996). [3] Phage display of proteases and macromolecular inhibitors. Methods in enzymology on CD-ROM/Methods in enzymology. 267. 52–68. 16 indexed citations

20.

Wang, Cheng‐I, Qing Yang, & Charles S. Craik. (1995). Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin. Journal of Biological Chemistry. 270(20). 12250–12256. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact